Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

BACKGROUND: The enhancer of zeste homolog 2 (EZH2) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association between EZH2 expression and prognosis in patients with renal cell carcinoma (RCC). METHODS: EZH2 pro...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Wagener, Nina, Macher-Goeppinger, Stephan, Pritsch, Maria, Hüsing, Johannes, Hoppe-Seyler, Karin, Schirmacher, Peter, Pfitzenmaier, Jesco, Haferkamp, Axel, Hoppe-Seyler, Felix, Hohenfellner, Markus
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2010
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2958940/
https://ncbi.nlm.nih.gov/pubmed/20920340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-524
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg